or Try an Advanced Search...

    Technical Analysis for CLNN - Clene Inc.

    Grade Last Price % Change Price Change
    F 0.33 -1.09% 0.00
    CLNN closed down 1.09 percent on Wednesday, July 3, 2024, on 56 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical CLNN trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Wide Bands Range Expansion -1.09%
    Gapped Down Weakness -1.09%
    Oversold Stochastic Weakness -1.09%
    Doji - Bullish? Reversal -8.29%
    Wide Bands Range Expansion -8.29%
    Older End-of-Day Signals for CLNN ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakdown about 7 hours ago
    Down 1% about 7 hours ago
    Possible NR7 about 7 hours ago
    Possible Inside Day about 7 hours ago
    Up 1% about 10 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    CLNN Chart by TradingView
    Basic chart:

    Profile

    Clene Nanomedicine Inc., a biopharmaceutical company, develops technology solutions for drug development. The company develops Clean-Surface Nanosuspension, a technology that produces clean-surface nanocrystal medicines. Its technology also provides a platform for a pipeline of new drug candidates with application across a spectrum of diseases with unmet medical needs. The company focuses on demyelinating disorders and oncology. Clene Nanomedicine Inc. was incorporated in 2012 and is based in Salt Lake City, Utah.
    Classification
    Keywords: Biotechnology Biopharmaceutical Life Sciences Health Sciences Medication Technology Solutions Drug Development Nanomedicine

    Is CLNN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 24 Clene to Present at H.C. Wainwright’s 5th Annual Neuro Perspectives Virtual Conference
    Jun 21 Clene Presents Preliminary Data for CNM-Au8® as a Potential Treatment for Rett Syndrome
    Jun 12 Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now
    Jun 12 Why Oracle Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
    Jun 11 Presenting on the Emerging Growth Conference 72 Day 1 on June 12 Register Now
    Jun 5 Clene to Present at the Emerging Growth Conference
    May 28 Clene Provides Update on Its NIH-Funded Expanded Access Program for CNM-Au8® in ALS (ACT-EAP)
    May 14 Clene to Present at Upcoming May Conferences
    May 9 Clene First Quarter 2024 Earnings: Misses Expectations
    May 8 Clene GAAP EPS of -$0.09
    See more CLNN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 0.85
    52 Week Low 0.25
    Average Volume 583,785
    200-Day Moving Average 0.42
    50-Day Moving Average 0.37
    20-Day Moving Average 0.37
    10-Day Moving Average 0.36
    Average True Range 0.04
    RSI (14) 38.65
    ADX 20.44
    +DI 15.53
    -DI 15.82
    Chandelier Exit (Long, 3 ATRs) 0.35
    Chandelier Exit (Short, 3 ATRs) 0.41
    Upper Bollinger Bands 0.43
    Lower Bollinger Band 0.32
    Percent B (%b) 0.09
    BandWidth 30.10
    MACD Line -0.01
    MACD Signal Line 0.00
    MACD Histogram -0.0058
    Fundamentals Value
    Market Cap 42.04 Million
    Num Shares 128 Million
    EPS -0.41
    Price-to-Earnings (P/E) Ratio -0.80
    Price-to-Sales 73.37
    Price-to-Book 2.51
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.35
    Resistance 3 (R3) 0.35 0.34 0.34
    Resistance 2 (R2) 0.34 0.34 0.34 0.34
    Resistance 1 (R1) 0.33 0.33 0.33 0.33 0.34
    Pivot Point 0.33 0.33 0.33 0.33 0.33
    Support 1 (S1) 0.32 0.33 0.32 0.32 0.31
    Support 2 (S2) 0.32 0.32 0.32 0.31
    Support 3 (S3) 0.31 0.32 0.31
    Support 4 (S4) 0.31